KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Sales (2016 - 2025)

Pfizer (PFE) has disclosed Return on Sales for 17 consecutive years, with 0.0% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales was 0.0% for Q4 2025 at Pfizer, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.01% in Q2 2024 to a low of 0.02% in Q3 2024.
  • A 5-year average of 0.0% and a median of 0.0% in 2022 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: decreased -20bps in 2021, then rose 1bps in 2022.
  • Pfizer's Return on Sales stood at 0.01% in 2021, then skyrocketed by 101bps to 0.0% in 2022, then crashed by -12108bps to 0.01% in 2023, then soared by 98bps to 0.0% in 2024, then surged by 314bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for PFE's Return on Sales are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).